… a new financing policy) and those that support the system by filling some gaps (e.g. procuring medicines) to produce improved shortterm outcomes (Chee et al., 2013). Given the variability of the…
… a new financing policy) and those that support the system by filling some gaps (e.g. procuring medicines) to produce improved shortterm outcomes (Chee et al., 2013). Given the variability of the…
… services and goods, such as service providers, health insurers, manufacturers and distributors of medicines and health products, as well as innovative and disruptive technologies with applications to the…
… services and goods, such as service providers, health insurers, manufacturers and distributors of medicines and health products, as well as innovative and disruptive technologies with applications to the…
… defined (inluding all targets related to 3 UHC dimensions FP,SC,PC) % availability of essential medicines, target 2020: 80% 1.3. Tracking and reporting on 3.8.1 % of adults with TB treated (78% in 2018)…
… of promoting a positive environment for innovative research and development, encouraging access to medicines and health care, and ensuring the sustainability of health systems, and we welcome an exchange of…
… Epub 20211211. 14. Perehudoff SK, Alexandrov NV, Hogerzeil HV. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries. Health Policy Plan.…
… Epub 20211211. 14. Perehudoff SK, Alexandrov NV, Hogerzeil HV. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries. Health Policy Plan.…
… également à remercier Sandra Mounier-Jack, le Dr Neil Spicer (London School of Hygiene & Tropical Medicines) et Tobias Luppe (Oxfam International) pour leurs contributions. Conception et mise en page: Ty…
